TAKE Solutions, a globally recognized domain intensive services provider across life sciences, announced its intent to capitalize on the opportunities in the high-growth clinical outsourcing environment. With an increasing emphasis on cost competitiveness, an emergence of disruptive technology solutions and increasing clinical trial complexity, the environment offers tremendous growth avenues for niche players like TAKE.
Analytics and software are driving tremendous growth in the USD 35 billion to USD 40 billion global life dciences outsourcing market. Large pharmaceutical companies continue to invest heavily in Life Sciences R&D, with clinical operations accounting for up to 80% of the average outsourceable R&D spend.
The company, which is on a transformational scale-up journey aims to grow in this space organically by leveraging its proven domain expertise, technology driven and insight backed offerings, as well as through strategic acquisitions.
Srinivasan HR, Vice Chairman and Managing Director, TAKE Solutions, “The clinical space is witnessing a high degree of consolidation among key players, who are looking to combine or augment their niche offerings with emerging innovations. In line with this industry development and our own growth strategy, we are looking to inorganically add to our portfolio of innovative offerings in the clinical and regulatory spaces.”
He further added, “We are actively scouting for and have identified prospects with an established presence in our dominant markets of North America and Europe, and are at various stages of discussion with them.”
TAKE Solutions delivers domain-intensive services in life sciences and supply chain Management. In the fast-growing Life Sciences space, TAKE offers clients a unique combination of a full-service CRO backed by industry insights and technology expertise. Its range of services span from clinical trials to regulatory submissions to post-marketing safety, all backed by insights derived through proprietary industry networks.